Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
American Society of Clinical Oncology (ASCO)
Online
2022-06-02
DOI
10.1200/jco.21.02745
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort
- (2021) Willem J. Koemans et al. Gastric Cancer
- Single-cell dissection of intratumoral heterogeneity and lineage diversity in metastatic gastric adenocarcinoma
- (2021) Ruiping Wang et al. NATURE MEDICINE
- Predicting postoperative peritoneal metastasis in gastric cancer with serosal invasion using a collagen nomogram
- (2021) Dexin Chen et al. Nature Communications
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Transcriptomic Profiling Identifies a Risk Stratification Signature for Predicting Peritoneal Recurrence and Micrometastasis in Gastric Cancer
- (2021) In-Seob Lee et al. CLINICAL CANCER RESEARCH
- REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer
- (2021) Katrin M. Sjoquist et al. GYNECOLOGIC ONCOLOGY
- Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study
- (2021) Sofie De Vuysere et al. BMC MEDICAL IMAGING
- Loss of ARID1A activates mTOR signaling and SOX9 in gastric adenocarcinoma—rationale for targeting ARID1A deficiency
- (2021) Xiaochuan Dong et al. GUT
- Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature
- (2021) Chuang Zhang et al. Frontiers in Immunology
- 1376O The effect of hyperthermic intraperitoneal chemotherapy (HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC) with synchronous peritoneal metastasis (PM): A randomized multicentre phase III trial (GASTRIPEC-I-trial)
- (2021) B. Rau et al. ANNALS OF ONCOLOGY
- Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity
- (2021) Andrew Chow et al. CANCER CELL
- Three-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 plus docetaxel versus S-1 alone in stage III gastric cancer: JACCRO GC-07
- (2021) Yoshihiro Kakeji et al. Gastric Cancer
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
- (2021) Yelena Y Janjigian et al. LANCET
- The clinicopathologic significance of Tks5 expression of peritoneal mesothelial cells in gastric cancer patients
- (2021) Atsushi Sugimoto et al. PLoS One
- Three-year outcomes of the randomized phase III SEIPLUS trial of extensive intraoperative peritoneal lavage for locally advanced gastric cancer
- (2021) Jing Guo et al. Nature Communications
- Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer
- (2021) Vikrant Kumar et al. Cancer Discovery
- 18F-Fludeoxyglucose–Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer
- (2021) Emma C. Gertsen et al. JAMA Surgery
- Primary and metastatic peritoneal surface malignancies
- (2021) Delia Cortés-Guiral et al. Nature Reviews Disease Primers
- Japanese gastric cancer treatment guidelines 2018 (5th edition)
- (2020) Gastric Cancer
- Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma
- (2020) Casey J. Allen et al. World Journal of Surgical Oncology
- Surgical management of gastric adenocarcinoma. Official expert recommendations delivered under the aegis of the French Association of Surgery (AFC)
- (2020) T. Voron et al. Journal of Visceral Surgery
- The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases
- (2020) ANNALS OF SURGICAL ONCOLOGY
- Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence
- (2020) Sanae Kaji et al. Gastric Cancer
- Safety, pharmacokinetics and tissue penetration of PIPAC paclitaxel in a swine model
- (2020) Hon Lyn Tan et al. EJSO
- Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer
- (2020) Mohammad Alyami et al. EJSO
- Peritoneal Metastatic Cancer Stem Cells of Gastric Cancer with Partial Mesenchymal-Epithelial Transition and Enhanced Invasiveness in an Intraperitoneal Transplantation Model
- (2020) Xiao-Hai Song et al. Gastroenterology Research and Practice
- Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
- (2020) Kohei Shitara et al. JAMA Oncology
- Enhancing anti-tumour efficacy with immunotherapy combinations
- (2020) Funda Meric-Bernstam et al. LANCET
- Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial
- (2020) Han Kwang Yang et al. Lancet Gastroenterology & Hepatology
- Mapping physical tumor microenvironment and drug delivery
- (2019) Hadi T. Nia et al. CLINICAL CANCER RESEARCH
- Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview
- (2019) Miguel Alberto et al. CLINICAL & EXPERIMENTAL METASTASIS
- Development and validation of an individualized nomogram to identify occult peritoneal metastasis in patients with advanced gastric cancer
- (2019) D Dong et al. ANNALS OF ONCOLOGY
- The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancer
- (2019) Koki Nakanishi et al. Gastric Cancer
- Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis
- (2019) Pierre-Emmanuel Bonnot et al. JOURNAL OF CLINICAL ONCOLOGY
- S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line treatment for advanced diffuse-type or mixed-type gastric/gastroesophageal junction adenocarcinoma: A randomized, phase 3 trial.
- (2019) Rui-hua Xu et al. JOURNAL OF CLINICAL ONCOLOGY
- Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
- (2019) Salah-Eddin Al-Batran et al. LANCET
- Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer
- (2019) Su‐Jin Shin et al. ONCOLOGIST
- Multiplex profiling of peritoneal metastases from gastric adenocarcinoma identified novel targets and molecular subtypes that predict treatment response
- (2019) Ruiping Wang et al. GUT
- A Stromal Niche Defined by Expression of the Transcription Factor WT1 Mediates Programming and Homeostasis of Cavity-Resident Macrophages
- (2019) Matthew B. Buechler et al. IMMUNITY
- Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications
- (2019) Mohammad Alyami et al. LANCET ONCOLOGY
- Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis
- (2019) Gandhi T. K. Boopathy et al. Frontiers in Cell and Developmental Biology
- Randomized clinical trial of extensive intraoperative peritoneal lavage versus standard treatment for resectable advanced gastric cancer (CCOG 1102 trial)
- (2019) K. Misawa et al. BRITISH JOURNAL OF SURGERY
- Intraperitoneal cancer-immune microenvironment promotes peritoneal dissemination of gastric cancer
- (2019) Shuichi Sakamoto et al. OncoImmunology
- Omental Tissue-Mediated Tumorigenesis of Gastric Cancer Peritoneal Metastases
- (2019) Olga Kersy et al. Frontiers in Oncology
- The Cytosolic DNA-Sensing cGAS–STING Pathway in Cancer
- (2019) John Kwon et al. Cancer Discovery
- Lauren Histologic Type Is the Most Important Factor Associated With Pattern of Recurrence Following Resection of Gastric Adenocarcinoma
- (2018) Jun H. Lee et al. ANNALS OF SURGERY
- Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer
- (2018) Koichi Sawaki et al. ANNALS OF SURGICAL ONCOLOGY
- Synaptotagmin XIII expression and peritoneal metastasis in gastric cancer
- (2018) M. Kanda et al. BRITISH JOURNAL OF SURGERY
- A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial
- (2018) Naoto Takahashi et al. Gastric Cancer
- Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial
- (2018) Hironori Ishigami et al. JOURNAL OF CLINICAL ONCOLOGY
- CCL2/CCL5 secreted by the stroma induce IL-6/PYK2 dependent chemoresistance in ovarian cancer
- (2018) Jennifer Pasquier et al. Molecular Cancer
- Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
- (2018) K Muro et al. ANNALS OF ONCOLOGY
- Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum
- (2018) WonJae Lee et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2018) Kohei Shitara et al. LANCET ONCOLOGY
- The 30-year experience—A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer
- (2017) Jacopo Desiderio et al. EUROPEAN JOURNAL OF CANCER
- Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007)
- (2017) Hitoshi Katai et al. Gastric Cancer
- Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells
- (2017) Takatsugu Ishimoto et al. GASTROENTEROLOGY
- Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma
- (2017) Dilsa Mizrak Kaya et al. JOURNAL OF SURGICAL ONCOLOGY
- Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Yoon-Koo Kang et al. LANCET
- Tissue Force Programs Cell Fate and Tumor Aggression
- (2017) Jason J. Northey et al. Cancer Discovery
- Gastric peritoneal carcinomatosis - a retrospective review
- (2017) Hwee Leong Tan et al. World Journal of Gastrointestinal Oncology
- Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) E. C. Smyth et al. ANNALS OF ONCOLOGY
- Staging laparoscopy in gastric cancer to detect peritoneal metastases: A systematic review and meta-analysis
- (2016) R.F. Ramos et al. EJSO
- Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan
- (2016) Koji Kono et al. Gastric Cancer
- Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis
- (2016) Daisuke Kobayashi et al. Gastric Cancer
- Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings
- (2016) Hironori Ishigami et al. Gastric Cancer
- Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?
- (2016) Dexter Yak Seng Chan et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Emergent role of the fractalkine axis in dissemination of peritoneal metastasis from epithelial ovarian carcinoma
- (2016) H Gurler Main et al. ONCOGENE
- Integrated Molecular Profiling of Human Gastric Cancer Identifies DDR2 as a Potential Regulator of Peritoneal Dissemination
- (2016) Junji Kurashige et al. Scientific Reports
- Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis
- (2016) Lucia Cottone et al. OncoImmunology
- Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin – a longitudinal experience from a prospectively collected database of 1108 patients
- (2015) Florian Seyfried et al. BMC CANCER
- Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases
- (2015) Hironori Shiozaki et al. JOURNAL OF SURGICAL ONCOLOGY
- Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
- (2015) Razvan Cristescu et al. NATURE MEDICINE
- Modern imaging techniques for preoperative detection of distant metastases in gastric cancer
- (2015) Robert M Kwee WORLD JOURNAL OF GASTROENTEROLOGY
- GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study
- (2014) Olivier Glehen et al. BMC CANCER
- Rates and Patterns of Recurrence after Curative Intent Resection for Gastric Cancer: A United States Multi-Institutional Analysis
- (2014) Gaya Spolverato et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- The role of the CCL22-CCR4 axis in the metastasis of gastric cancer cells into omental milky spots
- (2014) Liang Cao et al. Journal of Translational Medicine
- Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
- (2014) Sung Hoon Noh et al. LANCET ONCOLOGY
- Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
- (2014) Hansjochen Wilke et al. LANCET ONCOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites
- (2013) Joji Kitayama et al. ANNALS OF SURGICAL ONCOLOGY
- Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: Results of a multicentre retrospective study
- (2013) C. Honoré et al. EJSO
- Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association
- (2013) Hideaki Shimada et al. Gastric Cancer
- Factors predicting peritoneal recurrence in advanced gastric cancer: implication for adjuvant intraperitoneal chemotherapy
- (2013) Ju-Hee Lee et al. Gastric Cancer
- Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors
- (2013) Irene Thomassen et al. INTERNATIONAL JOURNAL OF CANCER
- Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
- (2013) Charles S Fuchs et al. LANCET
- Prediction of peritoneal recurrence by the mRNA level of CEA and MMP-7 in peritoneal lavage of gastric cancer patients
- (2013) Zhen Li et al. TUMOR BIOLOGY
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical Trial
- (2011) Xiao-Jun Yang et al. ANNALS OF SURGICAL ONCOLOGY
- Prognostic significance of peritoneal washing cytology in patients with gastric cancer
- (2011) S. D. Lee et al. BRITISH JOURNAL OF SURGERY
- The EGFR Ligands Amphiregulin and Heparin-Binding EGF-like Growth Factor Promote Peritoneal Carcinomatosis in CXCR4-Expressing Gastric Cancer
- (2011) K. Yasumoto et al. CLINICAL CANCER RESEARCH
- Japanese classification of gastric carcinoma: 3rd English edition
- (2011) Gastric Cancer
- Analysis for the Combination Expression of CK20, FABP1 and MUC2 is Sensitive for the Prediction of Peritoneal Recurrence in Gastric Cancer
- (2011) Y. Satoh et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
- (2011) Mitsuru Sasako et al. JOURNAL OF CLINICAL ONCOLOGY
- Investigation of the recurrence patterns of gastric cancer following a curative resection
- (2011) Jingyu Deng et al. SURGERY TODAY
- Peritoneal Carcinomatosis from Gastric Cancer: A Multi-Institutional Study of 159 Patients Treated by Cytoreductive Surgery Combined with Perioperative Intraperitoneal Chemotherapy
- (2010) Olivier Glehen et al. ANNALS OF SURGICAL ONCOLOGY
- Surgical treatment for peritoneal carcinomatosis from gastric cancer
- (2010) Y. Yonemura et al. EJSO
- Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial
- (2010) Jaffer A. Ajani et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of gastric cancer cell adhesion through transforming growth factor-beta1-mediated peritoneal fibrosis
- (2010) Zhi-Dong Lv et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Predictive Factors Improving Survival After Gastrectomy in Gastric Cancer Patients with Peritoneal Carcinomatosis
- (2010) Masayoshi Hioki et al. WORLD JOURNAL OF SURGERY
- Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer
- (2010) Paul H Sugarbaker World Journal of Gastrointestinal Oncology
- Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil
- (2009) Marcello F. Fanelli et al. International Journal of Clinical Oncology
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Peritoneal Metastasis: Detection with 16– or 64–Detector Row CT in Patients Undergoing Surgery for Gastric Cancer
- (2009) Su Jin Kim et al. RADIOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Locoregional treatment of peritoneal carcinomatosis from gastric cancer
- (2008) F. Bozzetti et al. JOURNAL OF SURGICAL ONCOLOGY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer
- (2008) Mitsuru Sasako et al. NEW ENGLAND JOURNAL OF MEDICINE
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started